Not applicableStudy completedNCT04590222
What this trial is testing
Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19
Who this might be right for
SARS-CoV2 Infection
Assistance Publique - Hôpitaux de Paris 51